MOFs for desulfurization of fuel oil: Recent advances and future insights

Nowadays, desulfurization of fuel oil has raised concern globally because of strict industrial and environmental legislations. Albeit hydrodesulfurization (HDS) has been extensively used in oil refineries to produce low sulfur oil (< 10 ppm) but not been proven as effective method for the removal of dibenzothiophene (DBT), benzothiophene (TH) and their derivatives. Subsequently, adsorptive desulfurization (ADS) and oxidative desulfurization (ODS) methods have been developed to achieve high removal efficiency. In the past decade, metal–organic frameworks (MOFs) and its composites as oxidative catalysts, as well as adsorbents, have attracted the researchers owing to high surface area, tunable properties, and reusable. The present review comprises use of MOFs and their composites for the removal of sulfur from fuel oil via ODS and ADS processes. Additionally, physicochemical properties of MOFs, mechanism, pros and cons of both process, regeneration, and future challenges have been discussed briefly. Moreover, current limitations and future prospective are also discussed.     

V2O5纳米片固载Pt纳米粒子催化剂的构建及其增强催化空气氧化脱硫性能

以铂系金属为代表的贵金属催化剂在工业反应中通常表现出优异的催化性能,这是因为其具有独特的d带电子结构和较高的价电子比.近年来,由于大气排放法规愈发严苛,铂系贵金属催化剂在催化空气氧化燃油脱硫方面的研究引起了广泛关注.在该催化反应中,铂系金属纳米粒子可以有效活化空气中的氧气,产生的活性氧物种可以将油品中的噻吩类硫化物氧化为其对应的强极性砜类物质,从而可以将其从非极性的油品中分离出来,有效实现油品中硫化物的深度氧化脱除.然而,在反应过程中铂系贵金属纳米粒子易发生流失和烧结,从而导致催化剂的失活.因此,急需寻找一类可以有效固载铂系贵金属纳米粒子的载体.在目前已报道的众多载体中,以ZrO₂、TiO₂、CeO₂、ZnO等为代表的过渡金属氧化物引起了广泛的关注.通常认为,铂系贵金属纳米粒子的d轨道电子和过渡金属氧化物之间可形成金属-载体强相互作用.然而,目前所使用的过渡金属氧化物载体的比表面积较小,从而导致铂系贵金属纳米粒子难以有效且均匀地分散于其表面.本文采用热膨胀气相剥离法制备了超薄V2O5纳米片,并通过超声辅助沉积法将Pt纳米粒子固载于其表面,从而得到一系列可高效活化空气氧化脱硫的催化剂(Pt NPs-n/V₂O₅纳米片).通过电感耦合等离子体光谱、高倍透射电镜、原子力显微镜、X射线光电子能谱、X射线衍射、拉曼光谱和氮气吸附脱附等方法对催化剂的结构和形貌进行了表征.结果表明,尺寸为4-5 nm的Pt纳米粒子可有效均匀分散于层数约为6层的V2O5纳米片表面;在空气氧化脱硫反应中,当催化剂中Pt理论负载量为2 wt%时,反应5 h后,油品的脱硫率可达99.1%,实现了硫化物的深度氧化脱除.该反应体系对不同硫浓度、不同含硫底物的油品均有较好的脱除效果,但对含有烯烃、芳烃的油品脱除效果较差.此外,催化剂循环使用7次后,其脱硫活性仍无明显下降,表现出优异的重复使用性能.对反应后的催化剂进行表征,发现Pt几乎不发生流失,这可能是由于Pt纳米粒子和V₂O₅纳米片之间形成了金属-载体强相互作用.该结果为其他空气氧化反应的有效进行提供了新思路.     

Protective Effect of Ferulic Acid against Hydrogen Peroxide Induced Apoptosis in PC12 Cells

Ferulic Acid (FA) is a highly abundant phenolic phytochemical which is present in plant tissues. FA has biological effects on physiological and pathological processes due to its anti-apoptotic and anti-oxidative properties, however, the detailed mechanism(s) of function is poorly understood. We have identified FA as a molecule that inhibits apoptosis induced by hydrogen peroxide (H₂O₂) or actinomycin D (ActD) in rat pheochromocytoma, PC12 cell. We also found that FA reduces H₂O₂-induced reactive oxygen species (ROS) production in PC12 cell, thereby acting as an anti-oxidant. Then, we analyzed FA-mediated signaling responses in rat pheochromocytoma, PC12 cells using antibody arrays for phosphokinase and apoptosis related proteins. This FA signaling pathway in PC12 cells includes inactivation of pro-apoptotic proteins, SMAC/Diablo and Bad. In addition, FA attenuates the cell injury by H₂O₂ through the inhibition of phosphorylation of the extracellular signal-regulated kinase (ERK). Importantly, we find that FA restores expression levels of brain-derived neurotrophic factor (BDNF), a key neuroprotective effector, in H₂O₂-treated PC12 cells. As a possible mechanism, FA increases BDNF by regulating microRNA-10b expression following H₂O₂ stimulation. Taken together, FA has broad biological effects as a neuroprotective modulator to regulate the expression of phosphokinases, apoptosis-related proteins and microRNAs against oxidative stress in PC12 cells.     

Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I,and the Chemotherapeutic Drug,Temozolomide against Glioblastoma Tumorspheres

Resident cancer cells with stem cell-like features induce drug tolerance, facilitating survival of glioblastoma (GBM). We previously showed that strategies targeting tumor bioenergetics present a novel emerging avenue for treatment of GBM. The objective of this study was to enhance the therapeutic effects of dual inhibition of tumor bioenergetics by combination of gossypol, an aldehyde dehydrogenase inhibitor, and phenformin, a biguanide compound that depletes oxidative phosphorylation, with the chemotherapeutic drug, temozolomide (TMZ), to block proliferation, stemness, and invasiveness of GBM tumorspheres (TSs). Combination therapy with gossypol, phenformin, and TMZ induced a significant reduction in ATP levels, cell viability, stemness, and invasiveness compared to TMZ monotherapy and dual therapy with gossypol and phenformin. Analysis of differentially expressed genes revealed up-regulation of genes involved in programmed cell death, autophagy, and protein metabolism and down-regulation of those associated with cell metabolism, cycle, and adhesion. Combination of TMZ with dual inhibitors of tumor bioenergetics may, therefore, present an effective strategy against GBM by enhancing therapeutic effects through multiple mechanisms of action.     

Ocular Delivery of Polyphenols: Meeting the Unmet Needs

Nature has become one of the main sources of exploration for researchers that search for new potential molecules to be used in therapy. Polyphenols are emerging as a class of compounds that have attracted the attention of pharmaceutical and biomedical scientists. Thanks to their structural peculiarities, polyphenolic compounds are characterized as good scavengers of free radical species. This, among other medicinal effects, permits them to interfere with different molecular pathways that are involved in the inflammatory process. Unfortunately, many compounds of this class possess low solubility in aqueous solvents and low stability. Ocular pathologies are spread worldwide. It is estimated that every individual at least once in their lifetime experiences some kind of eye disorder. Oxidative stress or inflammatory processes are the basic etiological mechanisms of many ocular pathologies. A variety of polyphenolic compounds have been proved to be efficient in suppressing some of the indicators of these pathologies in in vitro and in vivo models. Further application of polyphenolic compounds in ocular therapy lacks an adequate formulation approach. Therefore, more emphasis should be put in advanced delivery strategies that will overcome the limits of the delivery site as well as the ones related to the polyphenols in use. This review analyzes different drug delivery strategies that are employed for the formulation of polyphenolic compounds when used to treat ocular pathologies related to oxidative stress and inflammation.     

Preliminary Investigation of the Antioxidant,Anti-Diabetic,and Anti-Inflammatory Activity of Enteromorpha intestinalis Extracts

Marine algae are a promising source of potent bioactive agents against oxidative stress, diabetes, and inflammation. However, the possible therapeutic effects of many algal metabolites have not been exploited yet. In this regard, we explored the therapeutic potential of Enteromorpha intestinalis extracts obtained from methanol, ethanol, and hexane, in contrasting oxidative stress. The total phenolic (TPC) and flavonoids (TFC) content were quantified in all extracts, with ethanol yielding the best values (about 60 and 625 mg of gallic acid and rutin equivalents per gram of extract, respectively). Their antioxidant potential was also assessed through DPPH^•, hydroxyl radical, hydrogen peroxide, and superoxide anion scavenging assays, showing a concentration-dependent activity which was greater in the extracts from protic and more polar solvents. The α-amylase and α-glucosidase activities were estimated for checking the antidiabetic capacity, with IC₅₀ values of about 3.8 µg/mL for the methanolic extract, almost as low as those obtained with acarbose (about 2.8 and 3.3 µg/mL, respectively). The same extract also showed remarkable anti-inflammatory effect, as determined by hemolysis, protein denaturation, proteinase and lipoxygenase activity assays, with respectable IC₅₀ values (about 11, 4, 6, and 5 µg/mL, respectively), also in comparison to commercially used drugs, such as acetylsalicylic acid.     

Tandem Synthesis of Tetrasubstituted NH Pyrroles from Simple Nitriles

An efficient tandem route to obtain tetrasubstituted NH pyrroles in a one-pot manner has been developed, staring from simple nitriles, ethyl bromoacetates, and zinc. This reaction involves oxidative dimerization of the zinc bromide complex of β-enaminoesters using cerium ammonium nitrate (CAN) as an oxidant, affording 2,3,4,5-tetrasubstituted pyrroles in yields up to 91%.     

Quantification of Intracellular Thiols by HPLC-Fluorescence Detection

Biothiols, such as cysteine and glutathione, play important roles in various intracellular reactions represented by the redox equilibrium against oxidative stress. In this study, a method for intracellular thiol quantification using HPLC-fluorescence detection was developed. Thiols were derivatized with a thiol-specific fluorescence derivatization reagent, viz. ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate (SBD-F), followed by reversed-phase separation on an InertSustain AQ-C18 column. Six different SBD-thiols (homocysteine, cysteine, cysteinylglycine, γ-glutamylcysteine, glutathione, and N-acetylcysteine as an internal standard) were separated within 30 min using a citric buffer (pH 3.0)/MeOH mobile phase. The calibration curves of all the SBD-thiols had strong linearity (R² > 0.999). Using this developed method, the thiol concentrations of human chronic myelogenous leukemia K562 cell samples were found to be 5.5–153 pmol/1 × 10⁶ cells. The time-dependent effect of a thiol scavenger, viz. N-ethyl maleimide, on intracellular thiol concentrations was also quantified. This method is useful for elucidating the role of intracellular sulfur metabolism.     

Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential

Conifers have long been recognized for their therapeutic potential in different disorders. Alkaloids, terpenes and polyphenols are the most abundant naturally occurring phytochemicals in these plants. Here, we provide an overview of the phytochemistry and related commercial products obtained from conifers. The pharmacological actions of different phytochemicals present in conifers against bacterial and fungal infections, cancer, diabetes and cardiovascular diseases are also reviewed. Data obtained from experimental and clinical studies performed to date clearly underline that such compounds exert promising antioxidant effects, being able to inhibit cell damage, cancer growth, inflammation and the onset of neurodegenerative diseases. Therefore, an attempt has been made with the intent to highlight the importance of conifer-derived extracts for pharmacological purposes, with the support of relevant in vitro and in vivo experimental data. In short, this review comprehends the information published to date related to conifers’ phytochemicals and illustrates their potential role as drugs.